// App-Quantinova.ai

: Impact of Hemodynamic Ramp Test-Guided HVAD RPM and Medication Adjustments on Exercise Tolerance and Quality of Life: The RAMP-IT-UP Multicenter Study

Researchers

Presenter

  • N. Uriel

Principal Investigators

  • D. Burkhoff

  • J. Rich

  • S. Drakos

  • D. Banerjee

  • J. Teuteberg

  • G. Sayer

Medical Centers

  • University of Utah, Salt Lake City, UT

  • Northwestern University, Chicago, IL

  • The University of Chicago Medical Center, Chicago, IL

  • Columbia University, New York, NY

  • Stanford Univ, Palo Alto, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

Disease

  • Gastrointestinal bleeding

  • Aortic regurgitation

  • Heart muscle disease

  • Congestive heart failure

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • NCT03021239

Sponsors

  • Medtronic

Result

  • N/A